Xia L - Search Results

1

IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways.

Xia Y, Tao H, Hu Y, Chen Q, Chen X, Xia L, Zhou L, Wang Y, Bao Y, Huang S, Ren X, Lundy SK, Dai F, Li Q, Chang AE. Xia Y, et al. Among authors: xia l. Oncotarget. 2016 Sep 13;7(37):60461-60474. doi: 10.18632/oncotarget.11124. Oncotarget. 2016. PMID: 27528023 Free PMC article.

2

Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo.

Li H, Juan L, Xia L, Wang Y, Bao Y, Sun G. Li H, et al. Among authors: xia l. Med Sci Monit. 2016 Jul 25;22:2624-34. doi: 10.12659/msm.899950. Med Sci Monit. 2016. PMID: 27453171 Free PMC article.

3

Synergy of Dendritic Cell Vaccines and Avasimibe in Treatment of Head and Neck Cancer in Mice.

Chen X, Song Q, Xia L, Xu X. Chen X, et al. Among authors: xia l. Med Sci Monit. 2017 Sep 17;23:4471-4476. doi: 10.12659/msm.905814. Med Sci Monit. 2017. PMID: 28918429 Free PMC article.

4

The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome.

Xia L, Wang Y, Li T, Hu X, Chen Q, Liu L, Jiang B, Li C, Wang H, Wang S, Yang G, Bao Y. Xia L, et al. Cancer Med. 2019 Jun;8(6):2930-2941. doi: 10.1002/cam4.2193. Epub 2019 May 2. Cancer Med. 2019. PMID: 31050207 Free PMC article.

5

HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells.

Xia L, Wen L, Qin Y, Dobson HE, Zhang T, Comer FI, Hinrichs MJ, Oberst MD, Coats SR, Chang AE, Liu Y, Bao Y, Dai F, Wicha MS, Li Q. Xia L, et al. Cell Chem Biol. 2021 May 20;28(5):610-624.e5. doi: 10.1016/j.chembiol.2021.02.013. Epub 2021 Mar 11. Cell Chem Biol. 2021. PMID: 33711257 Free PMC article.

6

Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells.

Wang Y, Xia L, Lin J, Gong L, Xia Y, Xu Y, Liu L, Bao J, Zhang C, Chai Y, Li H. Wang Y, et al. Among authors: xia l, xia y. Transl Oncol. 2022 Dec;26:101549. doi: 10.1016/j.tranon.2022.101549. Epub 2022 Sep 30. Transl Oncol. 2022. PMID: 36191461 Free PMC article.

7

SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma.

Wang Y, Chen X, Li Y, Zhang Z, Xia L, Jiang J, Chai Y, Wang Z, Wan Y, Li T, Jin F, Li H. Wang Y, et al. Among authors: xia l. BMC Med Genomics. 2024 Apr 25;17(1):105. doi: 10.1186/s12920-024-01853-3. BMC Med Genomics. 2024. PMID: 38664735 Free PMC article.

8

SHP2 Inhibition Benefits Epidermal Growth Factor Receptor-mutated Non-Small Cell Lung Cancer Therapy.

Xia L, Wen L, Wang S. Xia L, et al. Mini Rev Med Chem. 2021;21(11):1314-1321. doi: 10.2174/1389557520666201127104104. Mini Rev Med Chem. 2021. PMID: 33245269 Review.

9

Synergistic effect of venetoclax and ibrutinib on ibrutinib-resistant ABC-type DLBCL cells.

Jin F, He L, Chen Y, Tian W, Liu L, Ge L, Qian W, Xia L, Yang M. Jin F, et al. Among authors: xia l. Braz J Med Biol Res. 2024 Oct 7;57:e13278. doi: 10.1590/1414-431X2024e13278. eCollection 2024. Braz J Med Biol Res. 2024. PMID: 39383379 Free PMC article.

10

Elevated expression of IL-12 and IL-23 in patients with primary immune thrombocytopenia.

Li Q, Yang M, Xia R, Xia L, Zhang L. Li Q, et al. Among authors: xia l, xia r. Platelets. 2015;26(5):453-8. doi: 10.3109/09537104.2014.934217. Epub 2014 Jul 15. Platelets. 2015. PMID: 25025295 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,799 results

Search Page

Filters